Click here - to use the wp menu builder

TFF Pharmaceuticals Raises $8.17 Million and Expands Leadership Team with New CFO and Director Appointments

May 30, 2019

AUSTIN, Texas–(BUSINESS WIRE)–TFF Pharmaceuticals announces completion of $8.17 Million Series A Preferred Stock; New Chief Financial Officer and Director are appointed.

http://www.businesswire.com/news/home/20190530005360/en/TFF-Pharmaceuticals-Raises-8.17-Million-Expands-Leadership/

TFF Pharmaceuticals Raises $8.17 Million and Expands Leadership Team with New CFO and Director Appointments

Recent Articles

Moderna Announces Supply Agreement to Provide 13 Million Doses of COVID-19 Vaccine Moderna to the Philippines

Covid-19: MedinCell Publishes an Extensive Ivermectin Safety Expert Analysis

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

U.S. FDA Approves Yescarta® for Relapsed or Refractory Follicular Lymphoma After Two or More Lines of Systemic Therapy

Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir